Form 4: Axon CRO Cameron Brooks Executes Stock Sale

Axon Enterprise Chief Revenue Officer Cameron Brooks sold 1,242 shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Cameron Brooks, Chief Revenue Officer of Axon Enterprise, Inc., sold 1,242 shares of common stock.
• The transaction occurred on June 4, 2026, at a price of $500 per share.
• Following the sale, the reporting person retains beneficial ownership of 49,709.933 shares.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was pre-planned and represents a small portion of the executive's total holdings.

Positives

• The transaction was conducted under a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without concerns regarding insider trading.

Negatives

• The sale represents a reduction in the executive's direct equity stake in the company.

Risks

• None identified in this filing.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales executed via 10b5-1 plans are routine corporate governance events and generally do not signal a change in management's outlook on company performance.

Comparison to Industry Standards

• The use of Rule 10b5-1 trading plans is the industry standard for corporate executives to manage personal liquidity while maintaining compliance with SEC regulations.

Stakeholder Impact

• Minimal impact on shareholders as the sale was pre-planned and represents a small fraction of the executive's total ownership.

Key Dates

Keywords

Axon Enterprise, AXON, Insider Trading, Form 4, Cameron Brooks, Chief Revenue Officer, Stock Sale